Precigen Latest News
- 03-17 AInvest NewsInsider Transactions Reported | Precigen(PGEN)saw insider trading activity on 3/17/2025
- 03-13 AInvest WirePrecigen to release FY24 financial results, host call on March 19.
- 03-03 AInvest WirePrecigen shares fall 1.20% after-hours; UltraCAR-T development update denied access.
- 03-01 AInvest ExclusiveWhy Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025
- 02-28 AInvest WirePrecigen Advances Pipeline with UltraCAR-T Development
- 02-25 MarketWatchBuy Rating for Precigen Driven by Promising Developments and Strong Market Potential of PRGN-2012
- 02-25 AInvest WireFDA Grants Precigen Priority Review for PRGN-2012 Gene Therapy for Respiratory Papillomatosis
- 02-25 AInvest WireFDA Grants Priority Review to Precigen's BLA for PRGN-2012 in RRP Treatment
- 02-25 MarketWatchPrecigen’s BLA for PRGN-2012 in papillomatosis granted priority review by FDA
- 02-25 AInvest WirePrecigen's gene therapy PRGN-2012 gets FDA priority review for RRP treatment.
- 02-20 NasdaqPrecigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
- 02-18 AInvest WirePrecigen shares up 2.55% intraday on successful platform proof.
- 02-16 AInvest WirePatient Capital Management Reduces Stake in Precigen Inc Amid Financial Challenges
- 02-14 AInvest WirePortland General Electric reports $3.01 GAAP, $3.14 adjusted EPS for FY24, initiates $3.13-$3.33 EPS for FY25.
- 02-13 AInvest WirePrecigen shares down 1.05% premarket after JPMorgan initiates at Neutral rating.
- 02-10 AInvest WirePrecigen shares fall 2.25% after-hours following class action lawsuit announcement.
- 02-10 AInvest WirePrecigen shares up 2.94% intraday after Pomerantz Law Firm lawsuit announcement.
- 02-10 AInvest WireIdentifying High Growth Tech Stocks in the US Market
- 02-05 AInvest WirePrecigen shares fall 1.95% after-hours following Stifel 2022 Virtual Cell Therapy Summit announcement.
- 02-03 AInvest NewsInsider Transactions Reported | Precigen(PGEN)saw insider trading activity on 2/3/2025
Show More News